Skip to Content

M LH1 (Hydrochlorothiazide and Lisinopril 12.5 mg / 10 mg)

Pill with imprint M LH1 is White, Round and has been identified as Hydrochlorothiazide and Lisinopril 12.5 mg / 10 mg. It is supplied by Mylan Pharmaceuticals Inc..

Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 12.5 mg / 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M LH1

Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1 Front
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1 Back
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1

Hydrochlorothiazide and Lisinopril

Imprint:
M LH1
Strength:
12.5 mg / 10 mg
Color:
White
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
ACE inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
microcrystalline cellulose
povidone
corn starch
sodium lauryl sulfate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0697 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide